Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Diabetes Drug Therapy Market 2018, Forecast to 2023

Publisher Name :
Date: 07-Jan-2019
No. of pages: 129

Diabetes is group of metabolic disorder, often referred as diabetes mellitus, results in high blood glucose levels. Body cells use glucose as a source of energy and insulin is important for the cells to absorb this glucose. When the body cells loose the capacity to respond to the insulin or body is not capable of producing sufficient insulin, it leads to an increase in blood glucose levels in the body. This condition is referred to as diabetes. Depending on the cause of development, it is divided into three types, which includes type 1 diabetes (body loses the capacity of producing sufficient insulin), type 2 diabetes (most common and body cells do not respond to insulin) and gestational diabetes (occurs in pregnant women). Among these, type 2 diabetes is the most common type and affects over 90% of the global diabetic patients.

Scope of the Report:

This report focuses on the Diabetes Drug Therapy in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Diabetes Drug Therapy is expected to grow at a CAGR of roughly xx% over the next five years, will reach 10000 million US$ in 2023, from 10000 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- Abbott Laboratories

- Mannkind Corporation

- Bristol Myers Squibb

- Medtronic

- AstraZeneca

- Eli Lilly and Company

- GlaxoSmithKline

- Sanofi

- Novo Nordisk

- Novartis International AG

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Glucagon-like peptide-1 (GLP-1) agonist

- Dipeptidyl-peptidase-4 (DPP-4) inhibitors

- Sodium glucose co-transporter 2 (SGLT2) inhibitors

- Insulin

- Others

Market Segment by Applications, can be divided into

- Type 1 Diabetes

- Type 2 Diabetes

- Gestational Diabetes

- Impaired Glucose Tolerance and Impaired Fasting Glycaemia

There are 15 Chapters to deeply display the global Diabetes Drug Therapy market.

Chapter 1, to describe Diabetes Drug Therapy Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Diabetes Drug Therapy, with sales, revenue, and price of Diabetes Drug Therapy, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Diabetes Drug Therapy, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Diabetes Drug Therapy market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Diabetes Drug Therapy sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Diabetes Drug Therapy Market 2018, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Diabetes Drug Therapy Introduction
1.2 Market Analysis by Type
1.2.1 Glucagon-like peptide-1 (GLP-1) agonist
1.2.2 Dipeptidyl-peptidase-4 (DPP-4) inhibitors
1.2.3 Sodium glucose co-transporter 2 (SGLT2) inhibitors
1.2.4 Insulin
1.2.5 Others
1.3 Market Analysis by Applications
1.3.1 Type 1 Diabetes
1.3.2 Type 2 Diabetes
1.3.3 Gestational Diabetes
1.3.4 Impaired Glucose Tolerance and Impaired Fasting Glycaemia
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Abbott Laboratories
2.1.1 Business Overview
2.1.1.1 Abbott Laboratories Description
2.1.1.2 Abbott Laboratories Headquarter, Main Business and Finance Overview
2.1.2 Abbott Laboratories Diabetes Drug Therapy Product Introduction
2.1.2.1 Diabetes Drug Therapy Production Bases, Sales Regions and Major Competitors
2.1.2.2 Diabetes Drug Therapy Product Information
2.1.3 Abbott Laboratories Diabetes Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Abbott Laboratories Diabetes Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Abbott Laboratories Diabetes Drug Therapy Market Share in 2017
2.2 Mannkind Corporation
2.2.1 Business Overview
2.2.1.1 Mannkind Corporation Description
2.2.1.2 Mannkind Corporation Headquarter, Main Business and Finance Overview
2.2.2 Mannkind Corporation Diabetes Drug Therapy Product Introduction
2.2.2.1 Diabetes Drug Therapy Production Bases, Sales Regions and Major Competitors
2.2.2.2 Diabetes Drug Therapy Product Information
2.2.3 Mannkind Corporation Diabetes Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Mannkind Corporation Diabetes Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Mannkind Corporation Diabetes Drug Therapy Market Share in 2017
2.3 Bristol Myers Squibb
2.3.1 Business Overview
2.3.1.1 Bristol Myers Squibb Description
2.3.1.2 Bristol Myers Squibb Headquarter, Main Business and Finance Overview
2.3.2 Bristol Myers Squibb Diabetes Drug Therapy Product Introduction
2.3.2.1 Diabetes Drug Therapy Production Bases, Sales Regions and Major Competitors
2.3.2.2 Diabetes Drug Therapy Product Information
2.3.3 Bristol Myers Squibb Diabetes Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Bristol Myers Squibb Diabetes Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Bristol Myers Squibb Diabetes Drug Therapy Market Share in 2017
2.4 Medtronic
2.4.1 Business Overview
2.4.1.1 Medtronic Description
2.4.1.2 Medtronic Headquarter, Main Business and Finance Overview
2.4.2 Medtronic Diabetes Drug Therapy Product Introduction
2.4.2.1 Diabetes Drug Therapy Production Bases, Sales Regions and Major Competitors
2.4.2.2 Diabetes Drug Therapy Product Information
2.4.3 Medtronic Diabetes Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Medtronic Diabetes Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Medtronic Diabetes Drug Therapy Market Share in 2017
2.5 AstraZeneca
2.5.1 Business Overview
2.5.1.1 AstraZeneca Description
2.5.1.2 AstraZeneca Headquarter, Main Business and Finance Overview
2.5.2 AstraZeneca Diabetes Drug Therapy Product Introduction
2.5.2.1 Diabetes Drug Therapy Production Bases, Sales Regions and Major Competitors
2.5.2.2 Diabetes Drug Therapy Product Information
2.5.3 AstraZeneca Diabetes Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 AstraZeneca Diabetes Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global AstraZeneca Diabetes Drug Therapy Market Share in 2017
2.6 Eli Lilly and Company
2.6.1 Business Overview
2.6.1.1 Eli Lilly and Company Description
2.6.1.2 Eli Lilly and Company Headquarter, Main Business and Finance Overview
2.6.2 Eli Lilly and Company Diabetes Drug Therapy Product Introduction
2.6.2.1 Diabetes Drug Therapy Production Bases, Sales Regions and Major Competitors
2.6.2.2 Diabetes Drug Therapy Product Information
2.6.3 Eli Lilly and Company Diabetes Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Eli Lilly and Company Diabetes Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Eli Lilly and Company Diabetes Drug Therapy Market Share in 2017
2.7 GlaxoSmithKline
2.7.1 Business Overview
2.7.1.1 GlaxoSmithKline Description
2.7.1.2 GlaxoSmithKline Headquarter, Main Business and Finance Overview
2.7.2 GlaxoSmithKline Diabetes Drug Therapy Product Introduction
2.7.2.1 Diabetes Drug Therapy Production Bases, Sales Regions and Major Competitors
2.7.2.2 Diabetes Drug Therapy Product Information
2.7.3 GlaxoSmithKline Diabetes Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 GlaxoSmithKline Diabetes Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global GlaxoSmithKline Diabetes Drug Therapy Market Share in 2017
2.8 Sanofi
2.8.1 Business Overview
2.8.1.1 Sanofi Description
2.8.1.2 Sanofi Headquarter, Main Business and Finance Overview
2.8.2 Sanofi Diabetes Drug Therapy Product Introduction
2.8.2.1 Diabetes Drug Therapy Production Bases, Sales Regions and Major Competitors
2.8.2.2 Diabetes Drug Therapy Product Information
2.8.3 Sanofi Diabetes Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Sanofi Diabetes Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Sanofi Diabetes Drug Therapy Market Share in 2017
2.9 Novo Nordisk
2.9.1 Business Overview
2.9.1.1 Novo Nordisk Description
2.9.1.2 Novo Nordisk Headquarter, Main Business and Finance Overview
2.9.2 Novo Nordisk Diabetes Drug Therapy Product Introduction
2.9.2.1 Diabetes Drug Therapy Production Bases, Sales Regions and Major Competitors
2.9.2.2 Diabetes Drug Therapy Product Information
2.9.3 Novo Nordisk Diabetes Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 Novo Nordisk Diabetes Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global Novo Nordisk Diabetes Drug Therapy Market Share in 2017
2.10 Novartis International AG
2.10.1 Business Overview
2.10.1.1 Novartis International AG Description
2.10.1.2 Novartis International AG Headquarter, Main Business and Finance Overview
2.10.2 Novartis International AG Diabetes Drug Therapy Product Introduction
2.10.2.1 Diabetes Drug Therapy Production Bases, Sales Regions and Major Competitors
2.10.2.2 Diabetes Drug Therapy Product Information
2.10.3 Novartis International AG Diabetes Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 Novartis International AG Diabetes Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global Novartis International AG Diabetes Drug Therapy Market Share in 2017
3 Global Diabetes Drug Therapy Market Competition, by Manufacturer
3.1 Global Diabetes Drug Therapy Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Diabetes Drug Therapy Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Diabetes Drug Therapy Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Diabetes Drug Therapy Manufacturer Market Share in 2017
3.4.2 Top 5 Diabetes Drug Therapy Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Diabetes Drug Therapy Market Analysis by Regions
4.1 Global Diabetes Drug Therapy Sales, Revenue and Market Share by Regions
4.1.1 Global Diabetes Drug Therapy Sales by Regions (2013-2018)
4.1.2 Global Diabetes Drug Therapy Revenue by Regions (2013-2018)
4.2 North America Diabetes Drug Therapy Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Diabetes Drug Therapy Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Diabetes Drug Therapy Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Diabetes Drug Therapy Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Diabetes Drug Therapy Sales, Revenue and Growth Rate (2013-2018)
5 North America Diabetes Drug Therapy by Countries, Type, Application and Manufacturers
5.1 North America Diabetes Drug Therapy Sales, Revenue and Market Share by Countries
5.1.1 North America Diabetes Drug Therapy Sales by Countries (2013-2018)
5.1.2 North America Diabetes Drug Therapy Revenue by Countries (2013-2018)
5.1.3 United States Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
5.1.4 Canada Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
5.1.5 Mexico Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
5.2 North America Diabetes Drug Therapy Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Diabetes Drug Therapy Sales by Manufacturers (2016-2017)
5.2.2 North America Diabetes Drug Therapy Revenue by Manufacturers (2016-2017)
5.3 North America Diabetes Drug Therapy Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Diabetes Drug Therapy Sales and Sales Share by Type (2013-2018)
5.3.2 North America Diabetes Drug Therapy Revenue and Revenue Share by Type (2013-2018)
5.4 North America Diabetes Drug Therapy Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Diabetes Drug Therapy Sales and Sales Share by Application (2013-2018)
5.4.2 North America Diabetes Drug Therapy Revenue and Revenue Share by Application (2013-2018)
6 Europe Diabetes Drug Therapy by Countries, Type, Application and Manufacturers
6.1 Europe Diabetes Drug Therapy Sales, Revenue and Market Share by Countries
6.1.1 Europe Diabetes Drug Therapy Sales by Countries (2013-2018)
6.1.2 Europe Diabetes Drug Therapy Revenue by Countries (2013-2018)
6.1.3 Germany Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
6.1.4 UK Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
6.1.5 France Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
6.1.6 Russia Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
6.1.7 Italy Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
6.2 Europe Diabetes Drug Therapy Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Diabetes Drug Therapy Sales by Manufacturers (2016-2017)
6.2.2 Europe Diabetes Drug Therapy Revenue by Manufacturers (2016-2017)
6.3 Europe Diabetes Drug Therapy Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Diabetes Drug Therapy Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Diabetes Drug Therapy Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Diabetes Drug Therapy Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Diabetes Drug Therapy Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Diabetes Drug Therapy Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Diabetes Drug Therapy by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Diabetes Drug Therapy Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Diabetes Drug Therapy Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Diabetes Drug Therapy Revenue by Countries (2013-2018)
7.1.3 China Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
7.1.4 Japan Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
7.1.5 Korea Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
7.1.6 India Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Diabetes Drug Therapy Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Diabetes Drug Therapy Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Diabetes Drug Therapy Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Diabetes Drug Therapy Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Diabetes Drug Therapy Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Diabetes Drug Therapy Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Diabetes Drug Therapy Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Diabetes Drug Therapy Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Diabetes Drug Therapy Revenue and Revenue Share by Application (2013-2018)
8 South America Diabetes Drug Therapy by Countries, Type, Application and Manufacturers
8.1 South America Diabetes Drug Therapy Sales, Revenue and Market Share by Countries
8.1.1 South America Diabetes Drug Therapy Sales by Countries (2013-2018)
8.1.2 South America Diabetes Drug Therapy Revenue by Countries (2013-2018)
8.1.3 Brazil Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
8.1.4 Argentina Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
8.1.5 Colombia Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
8.2 South America Diabetes Drug Therapy Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Diabetes Drug Therapy Sales by Manufacturers (2016-2017)
8.2.2 South America Diabetes Drug Therapy Revenue by Manufacturers (2016-2017)
8.3 South America Diabetes Drug Therapy Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Diabetes Drug Therapy Sales and Sales Share by Type (2013-2018)
8.3.2 South America Diabetes Drug Therapy Revenue and Revenue Share by Type (2013-2018)
8.4 South America Diabetes Drug Therapy Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Diabetes Drug Therapy Sales and Sales Share by Application (2013-2018)
8.4.2 South America Diabetes Drug Therapy Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Diabetes Drug Therapy by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Diabetes Drug Therapy Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Diabetes Drug Therapy Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Diabetes Drug Therapy Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
9.1.4 UAE Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
9.1.5 Egypt Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
9.1.7 South Africa Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Diabetes Drug Therapy Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Diabetes Drug Therapy Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Diabetes Drug Therapy Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Diabetes Drug Therapy Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Diabetes Drug Therapy Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Diabetes Drug Therapy Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Diabetes Drug Therapy Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Diabetes Drug Therapy Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Diabetes Drug Therapy Revenue and Revenue Share by Application (2013-2018)
10 Global Diabetes Drug Therapy Market Segment by Type
10.1 Global Diabetes Drug Therapy Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Diabetes Drug Therapy Sales and Market Share by Type (2013-2018)
10.1.2 Global Diabetes Drug Therapy Revenue and Market Share by Type (2013-2018)
10.2 Glucagon-like peptide-1 (GLP-1) agonist Sales Growth and Price
10.2.1 Global Glucagon-like peptide-1 (GLP-1) agonist Sales Growth (2013-2018)
10.2.2 Global Glucagon-like peptide-1 (GLP-1) agonist Price (2013-2018)
10.3 Dipeptidyl-peptidase-4 (DPP-4) inhibitors Sales Growth and Price
10.3.1 Global Dipeptidyl-peptidase-4 (DPP-4) inhibitors Sales Growth (2013-2018)
10.3.2 Global Dipeptidyl-peptidase-4 (DPP-4) inhibitors Price (2013-2018)
10.4 Sodium glucose co-transporter 2 (SGLT2) inhibitors Sales Growth and Price
10.4.1 Global Sodium glucose co-transporter 2 (SGLT2) inhibitors Sales Growth (2013-2018)
10.4.2 Global Sodium glucose co-transporter 2 (SGLT2) inhibitors Price (2013-2018)
10.5 Insulin Sales Growth and Price
10.5.1 Global Insulin Sales Growth (2013-2018)
10.5.2 Global Insulin Price (2013-2018)
10.6 Others Sales Growth and Price
10.6.1 Global Others Sales Growth (2013-2018)
10.6.2 Global Others Price (2013-2018)
11 Global Diabetes Drug Therapy Market Segment by Application
11.1 Global Diabetes Drug Therapy Sales Market Share by Application (2013-2018)
11.2 Type 1 Diabetes Sales Growth (2013-2018)
11.3 Type 2 Diabetes Sales Growth (2013-2018)
11.4 Gestational Diabetes Sales Growth (2013-2018)
11.5 Impaired Glucose Tolerance and Impaired Fasting Glycaemia Sales Growth (2013-2018)
12 Diabetes Drug Therapy Market Forecast (2018-2023)
12.1 Global Diabetes Drug Therapy Sales, Revenue and Growth Rate (2018-2023)
12.2 Diabetes Drug Therapy Market Forecast by Regions (2018-2023)
12.2.1 North America Diabetes Drug Therapy Market Forecast (2018-2023)
12.2.2 Europe Diabetes Drug Therapy Market Forecast (2018-2023)
12.2.3 Asia-Pacific Diabetes Drug Therapy Market Forecast (2018-2023)
12.2.4 South America Diabetes Drug Therapy Market Forecast (2018-2023)
12.2.5 Middle East and Africa Diabetes Drug Therapy Market Forecast (2018-2023)
12.3 Diabetes Drug Therapy Market Forecast by Type (2018-2023)
12.3.1 Global Diabetes Drug Therapy Sales Forecast by Type (2018-2023)
12.3.2 Global Diabetes Drug Therapy Market Share Forecast by Type (2018-2023)
12.4 Diabetes Drug Therapy Market Forecast by Application (2018-2023)
12.4.1 Global Diabetes Drug Therapy Sales Forecast by Application (2018-2023)
12.4.2 Global Diabetes Drug Therapy Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Diabetes Drug Therapy Picture
Table Product Specifications of Diabetes Drug Therapy
Figure Global Diabetes Drug Therapy CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Diabetes Drug Therapy CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Diabetes Drug Therapy by Types in 2017
Figure Glucagon-like peptide-1 (GLP-1) agonist Picture
Table Major Manufacturers of Glucagon-like peptide-1 (GLP-1) agonist
Figure Dipeptidyl-peptidase-4 (DPP-4) inhibitors Picture
Table Major Manufacturers of Dipeptidyl-peptidase-4 (DPP-4) inhibitors
Figure Sodium glucose co-transporter 2 (SGLT2) inhibitors Picture
Table Major Manufacturers of Sodium glucose co-transporter 2 (SGLT2) inhibitors
Figure Insulin Picture
Table Major Manufacturers of Insulin
Figure Others Picture
Table Major Manufacturers of Others
Figure Diabetes Drug Therapy Sales Market Share by Applications in 2017
Figure Type 1 Diabetes Picture
Figure Type 2 Diabetes Picture
Figure Gestational Diabetes Picture
Figure Impaired Glucose Tolerance and Impaired Fasting Glycaemia Picture
Figure United States Diabetes Drug Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Diabetes Drug Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Diabetes Drug Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Diabetes Drug Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure France Diabetes Drug Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure UK Diabetes Drug Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Diabetes Drug Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Diabetes Drug Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure China Diabetes Drug Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Diabetes Drug Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Diabetes Drug Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure India Diabetes Drug Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Diabetes Drug Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Diabetes Drug Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Diabetes Drug Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Diabetes Drug Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Diabetes Drug Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Diabetes Drug Therapy Revenue (Value) and Growth Rate (2013-2023)
Table Abbott Laboratories Headquarter, Established, Main Business and Finance Overview (2017)
Table Abbott Laboratories Diabetes Drug Therapy Production Bases, Sales Regions and Major Competitors
Table Abbott Laboratories Diabetes Drug Therapy Product
Table Abbott Laboratories Diabetes Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Abbott Laboratories Diabetes Drug Therapy Sales Market Share in 2017
Figure Global Abbott Laboratories Diabetes Drug Therapy Revenue Market Share in 2017
Table Mannkind Corporation Headquarter, Established, Main Business and Finance Overview (2017)
Table Mannkind Corporation Diabetes Drug Therapy Production Bases, Sales Regions and Major Competitors
Table Mannkind Corporation Diabetes Drug Therapy Product
Table Mannkind Corporation Diabetes Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Mannkind Corporation Diabetes Drug Therapy Sales Market Share in 2017
Figure Global Mannkind Corporation Diabetes Drug Therapy Revenue Market Share in 2017
Table Bristol Myers Squibb Headquarter, Established, Main Business and Finance Overview (2017)
Table Bristol Myers Squibb Diabetes Drug Therapy Production Bases, Sales Regions and Major Competitors
Table Bristol Myers Squibb Diabetes Drug Therapy Product
Table Bristol Myers Squibb Diabetes Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Bristol Myers Squibb Diabetes Drug Therapy Sales Market Share in 2017
Figure Global Bristol Myers Squibb Diabetes Drug Therapy Revenue Market Share in 2017
Table Medtronic Headquarter, Established, Main Business and Finance Overview (2017)
Table Medtronic Diabetes Drug Therapy Production Bases, Sales Regions and Major Competitors
Table Medtronic Diabetes Drug Therapy Product
Table Medtronic Diabetes Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Medtronic Diabetes Drug Therapy Sales Market Share in 2017
Figure Global Medtronic Diabetes Drug Therapy Revenue Market Share in 2017
Table AstraZeneca Headquarter, Established, Main Business and Finance Overview (2017)
Table AstraZeneca Diabetes Drug Therapy Production Bases, Sales Regions and Major Competitors
Table AstraZeneca Diabetes Drug Therapy Product
Table AstraZeneca Diabetes Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global AstraZeneca Diabetes Drug Therapy Sales Market Share in 2017
Figure Global AstraZeneca Diabetes Drug Therapy Revenue Market Share in 2017
Table Eli Lilly and Company Headquarter, Established, Main Business and Finance Overview (2017)
Table Eli Lilly and Company Diabetes Drug Therapy Production Bases, Sales Regions and Major Competitors
Table Eli Lilly and Company Diabetes Drug Therapy Product
Table Eli Lilly and Company Diabetes Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Eli Lilly and Company Diabetes Drug Therapy Sales Market Share in 2017
Figure Global Eli Lilly and Company Diabetes Drug Therapy Revenue Market Share in 2017
Table GlaxoSmithKline Headquarter, Established, Main Business and Finance Overview (2017)
Table GlaxoSmithKline Diabetes Drug Therapy Production Bases, Sales Regions and Major Competitors
Table GlaxoSmithKline Diabetes Drug Therapy Product
Table GlaxoSmithKline Diabetes Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global GlaxoSmithKline Diabetes Drug Therapy Sales Market Share in 2017
Figure Global GlaxoSmithKline Diabetes Drug Therapy Revenue Market Share in 2017
Table Sanofi Headquarter, Established, Main Business and Finance Overview (2017)
Table Sanofi Diabetes Drug Therapy Production Bases, Sales Regions and Major Competitors
Table Sanofi Diabetes Drug Therapy Product
Table Sanofi Diabetes Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Sanofi Diabetes Drug Therapy Sales Market Share in 2017
Figure Global Sanofi Diabetes Drug Therapy Revenue Market Share in 2017
Table Novo Nordisk Headquarter, Established, Main Business and Finance Overview (2017)
Table Novo Nordisk Diabetes Drug Therapy Production Bases, Sales Regions and Major Competitors
Table Novo Nordisk Diabetes Drug Therapy Product
Table Novo Nordisk Diabetes Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Novo Nordisk Diabetes Drug Therapy Sales Market Share in 2017
Figure Global Novo Nordisk Diabetes Drug Therapy Revenue Market Share in 2017
Table Novartis International AG Headquarter, Established, Main Business and Finance Overview (2017)
Table Novartis International AG Diabetes Drug Therapy Production Bases, Sales Regions and Major Competitors
Table Novartis International AG Diabetes Drug Therapy Product
Table Novartis International AG Diabetes Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Novartis International AG Diabetes Drug Therapy Sales Market Share in 2017
Figure Global Novartis International AG Diabetes Drug Therapy Revenue Market Share in 2017
Table Global Diabetes Drug Therapy Sales by Manufacturer (2016-2017)
Figure Global Diabetes Drug Therapy Sales Market Share by Manufacturer in 2016
Figure Global Diabetes Drug Therapy Sales Market Share by Manufacturer in 2017
Table Global Diabetes Drug Therapy Revenue by Manufacturer (2016-2017)
Figure Global Diabetes Drug Therapy Revenue Market Share by Manufacturer in 2016
Figure Global Diabetes Drug Therapy Revenue Market Share by Manufacturer in 2017
Table Global Diabetes Drug Therapy Price by Manufacturer (2016-2017)
Figure Top 3 Diabetes Drug Therapy Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Diabetes Drug Therapy Manufacturer (Revenue) Market Share in 2017
Figure Global Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
Figure Global Diabetes Drug Therapy Revenue and Growth Rate (2013-2018)
Table Global Diabetes Drug Therapy Sales by Regions (2013-2018)
Table Global Diabetes Drug Therapy Sales Market Share by Regions (2013-2018)
Table Global Diabetes Drug Therapy Revenue by Regions (2013-2018)
Figure Global Diabetes Drug Therapy Revenue Market Share by Regions in 2013
Figure Global Diabetes Drug Therapy Revenue Market Share by Regions in 2017
Figure North America Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
Figure North America Diabetes Drug Therapy Revenue and Growth Rate (2013-2018)
Figure Europe Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
Figure Europe Diabetes Drug Therapy Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Diabetes Drug Therapy Revenue and Growth Rate (2013-2018)
Figure South America Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
Figure South America Diabetes Drug Therapy Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Diabetes Drug Therapy Revenue and Growth Rate (2013-2018)
Figure North America Diabetes Drug Therapy Revenue and Growth Rate (2013-2018)
Table North America Diabetes Drug Therapy Sales by Countries (2013-2018)
Table North America Diabetes Drug Therapy Sales Market Share by Countries (2013-2018)
Figure North America Diabetes Drug Therapy Sales Market Share by Countries in 2013
Figure North America Diabetes Drug Therapy Sales Market Share by Countries in 2017
Table North America Diabetes Drug Therapy Revenue by Countries (2013-2018)
Table North America Diabetes Drug Therapy Revenue Market Share by Countries (2013-2018)
Figure North America Diabetes Drug Therapy Revenue Market Share by Countries in 2013
Figure North America Diabetes Drug Therapy Revenue Market Share by Countries in 2017
Figure United States Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
Figure Canada
  • Global Glycated Albumin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115
    According to our LPI (LP Information) latest study, the global Glycated Albumin market size was valued at US$ 419.7 million in 2023. With growing demand in downstream market, the Glycated Albumin is forecast to a readjusted size of US$ 593.8 million by 2030 with a CAGR of 5.1% during review period. The research report highlights the growth potential of the global Glycated Albumin market. Glycated Albumin are expected to show stable growth in the future market. However, product differenti......
  • Global Neuropathy Pain Treatment Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88
    According to our LPI (LP Information) latest study, the global Neuropathy Pain Treatment market size was valued at US$ 8341.5 million in 2023. With growing demand in downstream market, the Neuropathy Pain Treatment is forecast to a readjusted size of US$ 10560 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Neuropathy Pain Treatment market. Neuropathy Pain Treatment are expected to show stable growth in the futur......
  • Global Neuropathy Pain Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 92
    According to our (Global Info Research) latest study, the global Neuropathy Pain Treatment market size was valued at USD 8773.9 million in 2023 and is forecast to a readjusted size of USD 10910 million by 2030 with a CAGR of 3.2% during review period. This report studies the Neuropathy Pain Treatment market, Neuropathic pain is pain caused by damage or disease affecting the somatosensory nervous system. Neuropathy Pain Treatment is used for Neuropathic pain. Global Neuropath......
  • Global Type 1 Diabetes Therapeutics Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 106
    Market Overview of Global Type 1 Diabetes Therapeutics market: According to our latest research, the global Type 1 Diabetes Therapeutics market looks promising in the next 5 years. As of 2022, the global Type 1 Diabetes Therapeutics market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Type 1 diabetes, once known as juvenile diabetes or insulin-dependent diabetes, is a chronic condition in w......
  • Global Diabetic Neuropathy Professional Survey Report 2023, Forecast to 2028
    Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 104
    Diabetic neuropathy is a type of nerve damage that can occur if you have diabetes.  Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are com......
  • Global Diabetic Neuropathy Market Research Report 2023, Forecast to 2028
    Published: 26-Dec-2023        Price: US 2680 Onwards        Pages: 132
    Diabetic neuropathy is a type of nerve damage that can occur if you have diabetes.  Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are com......
  • Global Diabetic Nephropathy Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 23-Nov-2023        Price: US 3380 Onwards        Pages: 122
    Market Overview of Global Diabetic Nephropathy market: According to our latest research, the global Diabetic Nephropathy market looks promising in the next 5 years. As of 2022, the global Diabetic Nephropathy market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Diabetic nephropathy (DN) is a chronic loss of renal function in diabetic patients. This report covers a research ti......
  • Global Glycated Albumin Market Research Report 2023, Forecast to 2028
    Published: 21-Nov-2023        Price: US 2680 Onwards        Pages: 166
    Glycated albumin is albumin that has been glycated (bound to sugar). Albumin is the most common type of protein found in blood (~80% of circulating proteins) and is replaced in the body about every 20-25 days. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while ......
  • Global Glycated Albumin Professional Survey Report 2023, Forecast to 2028
    Published: 21-Nov-2023        Price: US 3280 Onwards        Pages: 106
    Glycated albumin is albumin that has been glycated (bound to sugar). Albumin is the most common type of protein found in blood (~80% of circulating proteins) and is replaced in the body about every 20-25 days. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs